Figure 3.

(a) Biologic activity and (b) neutralization of BLyS/APRIL HTs compared with those of BLyS and APRIL in TACI-Jurkat proliferation assays. APRIL, a proliferation-inducing ligand; BAFF-R, BAFF receptor; BCMA, B cell-maturation antigen; BLyS, B-lymphocyte stimulator; EC50, 50% effective concentration; HT, heterotrimer; IC50, 50% inhibition concentration; Ig, immunoglobulin; nz, trypsinized trimer without the "zipper" domain; TACI, transmembrane activator and CAML interactor; zz, trimer containing the "zipper" trimerization domain.

Dillon et al. Arthritis Research & Therapy 2010 12:R48   doi:10.1186/ar2959
Download authors' original image